Eli Lilly and AbCellera Team Up to Develop Coronavirus Antibodies: Under the terms of the agreement AbCellera and Lilly have committed to equally share initial development costs towards a product after which Lilly will be responsible for all… bioportfol.io/RRrSr9 #EliLilly

Lilly's Olumiant Gets Breakthrough Therapy Designation for Alopecia: The U.S. Food and Drug Administration granted Eli Lilly and Company and Incyte Corporation Breakthrough Therapy designation for baricitinib for alopecia areata. bioportfol.io/RS09ZZ #EliLilly

To Develop Coronavirus Treatment Lilly Taps AbCellera Antibody Platform: Eli Lilly will partner with Vancouver BCbased AbCellera to codevelop the most promising of 500 antibodies identified by the Canadian therapeutic antibody developer as… bioportfol.io/RS0YfG #EliLilly

Just announced Lilly will use our specialized research labs to help the StateHealthIN expand and accelerate COVID19 testing in Indiana. Read more httpse.lilly3a1Vdqz WeAreLillypic.twitter.comz9FBn7wqZd: Just announced Lilly will use our… bioportfol.io/RS7mDj #EliLilly

Comments criticize FDA guidance on insulin biosimilars: Eli Lilly and Novo Nordisk have submitted critical comments on the US Food and Drug Administrations FDA draft guidance on insulin biosimilars which suggests that immunogenicity testing may… bioportfol.io/RSDrCk #EliLilly

Eli Lilly shifts clinical trial activity during coronavirus: The pharmaceutical company has announced several changes to its clinical trial activities in the face of the global pandemic. bioportfol.io/RSPqSL #EliLilly

Eli Lilly pauses enrolment in ongoing trials delays new study starts citing strain coronavirus placing on healthcare system httpswww.firstwordpharma.comnode1709942tsid28&regionid6Â: Eli Lilly pauses enrolment in ongoing trials delays new study… bioportfol.io/RSPqT7 #EliLilly

Lilly Galapagos halt trials as coronavirus deepens impact on drug research: The moves likely herald similar announcements by other large drugmakers as medical centers focus resources on treating patients with COVID19. bioportfol.io/RSQ952 #EliLilly

Following November Adcom Vote FDA Rejects Lilly and Boehringer's Jardiance for Type 1 Diabetes: The U.S. Food and Drug Administration issued a Completed Response Letter of Eli Lilly and Company and Boehringer Ingelheims Jardiance empaglifozin… bioportfol.io/RSQcNk #EliLilly

Eli Lilly Among Companies Pausing Some Clinical Trials Due to COVID19 Pandemic: This morning the Indianapolisbased company said it will delay most new study starts and pause enrollment in most ongoing studies in light of the COVID19 pandemic. bioportfol.io/RSQcQn #EliLilly

Eli Lilly and Company Insulins A Century of Innovation.: Eli Lilly and Company has played a pivotal role in the development of insulin products since its discovery in 1921. Through their dedication to pharmaceutical innovation Josiah K. Lilly Sr.… bioportfol.io/RScvJh #Lilly